The epidemic of methicillin-resistant Staphylococcus aureus colonization and infection in children: Effects on the community, health systems, and physician practices

Pediatric Annals

Volumn 36, Issue 7, 2007, Pages 404-412

  Fergie, Jaime ^a,b   Purcell, Kevin ^c,d  

^a DRISCOLL CHILDREN S HOSPITAL   (United States)

^b TEXAS A M COLLEGE OF MEDICINE   (United States)

^c Christus Santa Rosa Health Care   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; LINEZOLID; MINOCYCLINE; NAFCILLIN; RIFAMPICIN; VANCOMYCIN;

BACTERIAL COLONIZATION; BACTERIUM ISOLATE; CHILD HEALTH; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE TRANSMISSION; EPIDEMIC; HUMAN; INFECTION PREVENTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT; RISK FACTOR; STAPHYLOCOCCUS INFECTION; UNITED STATES;

EID: 34547400559     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/0090-4481-20070701-08     Document Type: Review

References (45)

1. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no predisposing risk. JAMA. 1998;279(8):593-598.
2. Frank AL, Marcinak JF, Mangat PD, Schreckenberger PC. Community-acquired and clindamycin-susceptible methicillin-resistant Staphylococcus aureus in children. Pediatr Infect Dis J. 1999;18(11):993-1000.
3. Fergie JE, Purcell K. Community-acquired Dis J. 2001;20(9):860-863.
4. Purcell K, Fergie J. Exponential increase in community-acquired methicillin-resistant Staphylococcus aureus in South Texas children. Pediatr Infect Dis J. 2002;21(10):988-989.
5. Sattler CA, Mason EO, Kaplan SL. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infections in children. Pediatr Infect Dis J. 2002;21(10):910-916.
6. Buckingham SC, McDougal LK, Cathey LD, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee Children's Hospital. Pediatr Infect Dis J. 2004;23(7):619-624.
7. Kaplan SL, Hulten KG, Gonzalez BE, et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis. 2005;40(12):1785-1791.
8. Purcell K, Fergie J. Epidemic of community-acquired methicillin-resistant Staphylococcus aureus infections: a 14-year study at Driscoll Children's Hospital. Arch Pediatr Adolesc Med. 2005;159(10):980-985.
9. Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcal aureus - Minnesota and North Dakota, 1997-1999. JAMA. 1999;282(12):1123-1125.
10. Hussain FM, Boyle-Vavra S, Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus colonization in healthy children attending an outpatient pediatric clinic. Pediatr Infect Dis J. 2001;20(8):763-767.
11. Nakamura MM, Rohling KL, Shashaty M, Lu H, Tang YW, Edwards KM. Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in the community pediatric population. Pediatr Infect Dis J. 2002;21(10):917-921.
12. Cheng Immergluck L, Kanungo S, Schwartz A, McIntyre A, Schreckenberger PC, Diaz PS. Prevalence of Streptococcus pneumoniae and Staphylococcus aureus nasopharyngeal colonization in healthy children in the United States. Epidemiol Infect. 2004;132(2):159-166.
13. Creech CB, Kernodle DS, Alsentzer A, Wilson C, Edwards KM. Increasing rates of nasal carriage of methicillin-resistant Staphylococcus aureus in healthy children. Pediatr Infect Dis J. 2005;24(7):617-621.
14. Adcock PM, Pastor P, Medley F, Patterson JE, Murphy TV. Methicilhn-resistant Staphylococcus aureus in two child care centers. J Infect Dis. 1998;178(2):577-580.
15. Shahin R, Johnson IL, Jamieson F, McGeer A, Tolkin J, Ford-Jones EL. Methicillin-resistant Staphylococcus aureus carriage in a child care center following a case of disease. Arch Pediatr Adolesc Med. 1999;153(8):864-868.
16. Suggs AH, Maranan MC, Boyle-Vavra S, Daum RS. Methicillin-resistant and borderline methicillin-resistant asymptomatic Staphylococcus aureus colonization in children without identifiable risk factors. Pediatr Infect Dis J. 1999;18(5):410-414.
17. Foglia EE, Dubberke E, Reno H, et al. Nasal carriage of Staphylococcus aureus and MRSA: point prevalence study in children. Presented at Society for Healthcare Epidemiology of America 2005 Annual Meeting. April 9-2, 2005; Los Angeles, CA.
18. Alfaro C, Mascher-Denen M, Fergie J, Purcell K. Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in patients admitted to Driscoll Children's Hospital. Pediatr Infect Dis J. 2006;25(5):459-461.
19. Ito T, Ma XX, Takeuchi F, Okuma K, Yuzawa H, Hiramatsu K. Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC. Antimicrob Agents Chemother. 2004;48(7):2637-2651.
20. McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol. 2003;41(11):5113-5120.
21. Diep BA, Gill SR, Chang RF, et al: Complete genome sequence of USA 300, an epidemic clone of community-acquired methicillin-resistant Staphylococcus aureus. Lancet. 2006;367(9512):731-739.
22. Seybold U, Kourbatova EV, Johnson JG, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 genotype as a major cause of healthcare-associated blood stream infections. Clin Infect Dis. 2006;42(5):647-656.
23. Zaoutis TE, Toltzis P, Chu J, et al. Clinical and molecular epidemiology of community-acquired methicillin- resistant Staphylococcus aureus infections among children with risk factors for healthcare-associated infections, 2001-2003. Pediatr Infect Dis J. 2006;25(4):343-348.
24. Purcell K, Fergie J. Increase in hospitalizations for cellulitis and abscess concurrent with the epidemic of community-acquired methicillin-resistant Staphylococcus aureus infections in children. Presented at 2005 Annual Meeting of the Pediatric Academic Societies. May 14-17,2005; Washington, D.C.
25. Purcell K, Fergie J, Peterson MD. Economic impact of the community-acquired methicillin-resistant Staphylococcus aureus epidemic on the Driscoll Children's Health Plan. Pediatr Infect Dis J. 2006;25(2):178-180.
26. Marchaim D, Schwaber M, Kaye K, et al. The burden of methicillin- resistant Staphylococcus aureus infections on patients hospitalized in the US. Presented at 46th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy. September 27-30, 2006; San Francisco.
27. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev. 1997;10(3):505-520.
28. Huang SS, Platt R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis. 2003;36(3):281-285.
29. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med. 2001;344(1):11-16.
30. Wertheim HFL, Vos MC, Ott A, et al. Risk and outcome of nosocomial Staphylococcus aureus bacteremia in nasal carriers versus non-carriers. Lancet. 2004;364(9435):703-705.
31. Davis KA, Stewart JJ, Crouch HK, Florez CE, Hospenthal DR. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis. 2004;39(6):776-782.
32. Ellis MW, Hospenthal DR, Dooley DP, Gray PJ, Murrak CK. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis. 2004;39(7):971-979.
33. Adem PV, Montgomery CP, Husain AN, et al. Staphylococcus aureus sepsis and Waterhouse-Friderichsen syndrome in children. N Engl J Med. 2005;353(26):1245-1251.
34. Fortunov RM, Hulten KG, Hammerman WA, Mason EO, Kaplan SL. Community-acquired Staphylococcus aureus infections in term and near-term previously healthy neonates. Pediatrics. 2006;118(3):874-881.
35. Frank AL, Marcinak JF, Mangat PD, et al. Clindamycin treatment of methicilhn-resistant Staphylococcus aureus infections in children. Pediatr Infect Dis J. 2002;21(6):530-534.
36. Lee MC, Rios AM, Aten MF, et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin- resistant Staphylococcus aureus. Pediatr Infect Dis J. 2004;23(2):123-127.
37. Wunderink RG, Rello J, Cammarata SK, Croos-Dabrera RV, Kollef MH. Linezolid vs Vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest. 2003;124(5):1789-1797.
38. Ardura Mi, Mejias A, McCracken GH, et al. Daptomycin therapy for multi-drug resistant gram-positive bacterial infections in children. Presented at 44th Annual Meeting of the Infectious Diseases Society of America. October 12-15,2006; Toronto, Ontario, Canada.
39. Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol. 2003;24(5):362-386.
40. Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus infections among competitive sports participants - Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003. MMWR Morb Mortal Wkly Rep. 2003;52(33):793-795.
41. Garner JS, CDC Hospital Infection Control Practices Advisory Committee. Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol. 1996;17(1):53-80.
42. Mulligan ME, Murray-Leisure KA. Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med. 1993;94(3):313-328.
43. Cepeda JA, Whitehouse T, Cooper B, et al. Isolation of patients in single rooms or cohorts to reduce the spread of MRSA in intensive care units: prospective two-centre study. Lancet. 2005;365(9456):295-304.
44. Kalmeijer MD, Coertjens H, van Nieuwland-Bollen PM, et al. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin Infect Dis. 2002;35(4):353-358.
45. Perl TM, Cullen JJ, Wenzel RP, et al. Mupirocin and the Risk of Staphylococcus aureus Study Team. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med. 2002;346(24):1871-1877.